| For: | Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial. World J Stem Cells 2024; 16(12): 1012-1021 [PMID: 39734483 DOI: 10.4252/wjsc.v16.i12.1012] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v16/i12/1012.htm |
| Number | Citing Articles |
| 1 |
Dolores Javier Sánchez-González, Nayeli Isabel Trejo-Bahena, Enrique Méndez-Bolaina, Israel Ramírez-Sánchez, Elena de la Cruz Herrera-Cogco, Gabriela Gutiérrez-Salmeán. Integrative therapeutic strategies in chronic kidney disease: from precision to regeneration. Academia Medicine and Health 2025; 2(4) doi: 10.20935/AcadMedHealth8045
|
| 2 |
Takayasu Ohtake, Amankeldi A. Salybekov, Tsutomu Sato, Shigeaki Okamura, Masaki Yazawa, Yuki Yano, Mehdi Hassanpour, Mitsuru Yanai, Makoto Imagawa, Takayuki Asahara, Shuzo Kobayashi. Efficacy of Repeated Administration of Cultured Human CD34+ Cells Against Streptozotocin-Induced Diabetic Nephropathy in Rats. Cells 2025; 14(22): 1766 doi: 10.3390/cells14221766
|
